The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force.
作者信息
Colvin B T, Barrowcliffe T W
机构信息
British Society for Haematology, London.
出版信息
J Clin Pathol. 1993 Feb;46(2):97-103. doi: 10.1136/jcp.46.2.97.
Abstract
摘要
相似文献
1
The British Society for Haematology Guidelines on the use and monitoring of heparin 1992: second revision. BCSH Haemostasis and Thrombosis Task Force.英国血液学学会肝素使用与监测指南1992：第二次修订版。英国血液学学会止血与血栓形成特别工作组。
J Clin Pathol. 1993 Feb;46(2):97-103. doi: 10.1136/jcp.46.2.97.
2
Audit of oral anticoagulant treatment. The BCSH Haemostasis and Thrombosis Task Force of the British Society for Haematology.口服抗凝治疗审计。英国血液学学会BCSH止血与血栓形成特别工作组。
J Clin Pathol. 1993 Dec;46(12):1069-70. doi: 10.1136/jcp.46.12.1069.
3
Immune thrombocytopenic purpura in pregnancy.妊娠期免疫性血小板减少性紫癜
Curr Opin Hematol. 2007 Sep;14(5):574-80. doi: 10.1097/MOH.0b013e3282bf6dc2.
4
Abstracts of the 46th Annual Scientific Meeting of the British Society for Haematology incorporating the Netherlands and British Haemostasis and Thrombosis Societies, 3-5 April 2006, Edinburgh, United Kingdom.英国血液学学会第46届年度科学会议摘要，该会议联合了荷兰和英国止血与血栓形成学会，于2006年4月3日至5日在英国爱丁堡举行。
Br J Haematol. 2006 Apr;133 Suppl 1:1-121. doi: 10.1111/j.1365-2141.2006.06027.x.
5
Guidelines on platelet function testing. The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force.
J Clin Pathol. 1988 Dec;41(12):1322-30. doi: 10.1136/jcp.41.12.1322.
6
7
[Anticoagulation of the extracorporeal circuit in chronic hemodialysis].[慢性血液透析中体外循环的抗凝]
Nephrologie. 1998;19(4):223-5.
8
Guidelines on oral anticoagulation: second edition. British Society for Haematology. British Committee for Standards in Haematology. Haemostasis and Thrombosis Task Force.口服抗凝治疗指南：第二版。英国血液学学会。英国血液学标准委员会。止血与血栓形成特别工作组。
J Clin Pathol. 1990 Mar;43(3):177-83. doi: 10.1136/jcp.43.3.177.
9
10
British society for haematology--report on the specialty of haematology.英国血液学学会——血液学专业报告
Br Med J. 1970 Jun 27;2(5712):788. doi: 10.1136/bmj.2.5712.788.
引用本文的文献
1
D-Dimer Level Associated with Amount of Sinus involvement Using Digital Subtraction Angiography on Cerebral Venous Thrombosis Patients.使用数字减影血管造影术对脑静脉血栓形成患者进行研究：D - 二聚体水平与鼻窦受累程度的相关性
J Blood Med. 2023 Apr 17;14:303-308. doi: 10.2147/JBM.S399661. eCollection 2023.
2
Anticoagulation therapy in children.儿童抗凝治疗
Paediatr Drugs. 2003;5(12):803-20. doi: 10.2165/00148581-200305120-00004.
3
Dermatan sulfate versus unfractionated heparin for the prevention of venous thromboembolism in patients undergoing surgery for cancer. A cost-effectiveness analysis.硫酸皮肤素与普通肝素用于癌症手术患者预防静脉血栓栓塞的成本效益分析。
Pharmacoeconomics. 2001 Jan;19(1):57-68. doi: 10.2165/00019053-200119010-00004.
4
Outpatient Therapy of Deep Vein Thrombosis.
J Thromb Thrombolysis. 1998 Jan;5 Suppl 1(3):29-35. doi: 10.1023/a:1013232803747.
5
Prevention and treatment of venous thromboembolism.静脉血栓栓塞症的预防与治疗。
Drugs. 1996 Jul;52(1):71-92. doi: 10.2165/00003495-199652010-00006.
6
Uses of heparin.
BMJ. 1993 Apr 3;306(6882):871-2. doi: 10.1136/bmj.306.6882.871.
7
Maintaining blood flow in the extracorporeal circuit: haemostasis and anticoagulation.维持体外循环中的血流：止血与抗凝。
Intensive Care Med. 1995 Jan;21(1):84-93. doi: 10.1007/BF02425162.
本文引用的文献
1
An objective study of alternative methods of heparin administration.肝素给药替代方法的客观研究。
Thromb Res. 1980;18(1-2):177-87. doi: 10.1016/0049-3848(80)90182-6.
2
Control of heparinisation during cardiopulmonary bypass. Experience with the activated clotting time method.
Anaesthesia. 1980 Mar;35(3):250-6. doi: 10.1111/j.1365-2044.1980.tb05092.x.
3
Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin.
Gynecol Obstet Invest. 1982;14(2):127-41. doi: 10.1159/000299460.
4
Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.肝素寡糖的抗凝活性及其被血小板第4因子中和的作用
Biochem J. 1984 Mar 15;218(3):725-32. doi: 10.1042/bj2180725.
5
Prolonged heparin therapy in pregnancy causes bone demineralization.
Br J Obstet Gynaecol. 1983 Dec;90(12):1129-34. doi: 10.1111/j.1471-0528.1983.tb06459.x.
6
Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement.全髋关节置换术后预防深静脉血栓形成中，调整剂量皮下注射肝素与固定剂量皮下注射肝素的比较
N Engl J Med. 1983 Oct 20;309(16):954-8. doi: 10.1056/NEJM198310203091605.
7
Effect of heparin and heparin fractions on platelet aggregation.
J Clin Invest. 1980 Jan;65(1):64-73. doi: 10.1172/JCI109661.
8
Objective assessment of heparin requirements for hemodialysis in humans.
J Lab Clin Med. 1984 Apr;103(4):643-52.
9
Bioavailability and antagonization of the low molecular weight heparin CY 216 in man.
Thromb Res. 1986 Nov 15;44(4):549-54. doi: 10.1016/0049-3848(86)90333-6.
10
Risks of anticoagulant therapy in pregnant women with artificial heart valves.有人工心脏瓣膜的孕妇接受抗凝治疗的风险。
N Engl J Med. 1986 Nov 27;315(22):1390-3. doi: 10.1056/NEJM198611273152205.
Zotero 插件